These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27600062)

  • 1. How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital.
    Gouverneur A; Rouyer M; Grelaud A; Robinson P; Colombani F; Terrebonne E; Smith D; Fourrier-Réglat A; Noize P
    Fundam Clin Pharmacol; 2017 Feb; 31(1):104-109. PubMed ID: 27600062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia.
    Parakh S; Wong HL; Rai R; Ali S; Field K; Shapiro J; Wong R; Nott L; Gibbs P; Yip D
    J Geriatr Oncol; 2015 Sep; 6(5):387-94. PubMed ID: 26190441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life.
    Gouverneur A; Bezin J; Jové J; Bosco-Lévy P; Fourrier-Réglat A; Noize P
    J Am Geriatr Soc; 2019 May; 67(5):913-919. PubMed ID: 30840323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between hospital discharge diagnosis codes and medical records to identify metastatic colorectal cancer and associated comorbidities in elderly patients.
    Gouverneur A; Dolatkhani D; Rouyer M; Grelaud A; Francis F; Gilleron V; Fourrier-Réglat A; Noize P
    Rev Epidemiol Sante Publique; 2017 Aug; 65(4):321-325. PubMed ID: 28576381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
    Phelip JM; Tougeron D; Léonard D; Benhaim L; Desolneux G; Dupré A; Michel P; Penna C; Tournigand C; Louvet C; Christou N; Chevallier P; Dohan A; Rousseaux B; Bouché O
    Dig Liver Dis; 2019 Oct; 51(10):1357-1363. PubMed ID: 31320305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
    Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
    Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
    Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients.
    Aparicio T; Jouve JL; Teillet L; Gargot D; Subtil F; Le Brun-Ly V; Cretin J; Locher C; Bouché O; Breysacher G; Charneau J; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Mitry E
    J Clin Oncol; 2013 Apr; 31(11):1464-70. PubMed ID: 23460711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
    Tomita Y; Karapetis CS; Ullah S; Townsend AR; Roder D; Beeke C; Roy AC; Padbury R; Price TJ
    Acta Oncol; 2016; 55(4):480-5. PubMed ID: 26878155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer.
    Razenberg LG; Creemers GJ; Beerepoot LV; Vos AH; van de Wouw AJ; Maas HA; Lemmens VE
    Acta Oncol; 2016 Dec; 55(12):1443-1449. PubMed ID: 27585122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'real-life' impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: a large Israeli retrospective cohort study.
    Hammerman A; Greenberg-Dotan S; Battat E; Feldhamer I; Bitterman H; Brenner B
    Acta Oncol; 2015 Feb; 54(2):164-70. PubMed ID: 25350524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
    Zhao Z; Pelletier E; Barber B; Bhosle M; Wang S; Gao S; Klingman D
    Curr Med Res Opin; 2012 Feb; 28(2):221-9. PubMed ID: 22171947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and treatment propensity in elderly patients aged over 80 years with colorectal cancer.
    Jung YH; Kim JY; Jang YN; Yoo SH; Kim GH; Lee KM; Lee IK; Chung SM; Woo IS
    Korean J Intern Med; 2018 Nov; 33(6):1182-1193. PubMed ID: 29166760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study.
    Keikes L; Koopman M; Stuiver MM; Lemmens VEPP; van Oijen MGH; Punt CJA
    Acta Oncol; 2020 Apr; 59(4):395-403. PubMed ID: 32048563
    [No Abstract]   [Full Text] [Related]  

  • 16. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.
    Ward P; Hecht JR; Wang HJ; Dichmann R; Liem AK; Chan D; Patel R; Hu EH; Tchekmedyian NS; Wainberg ZA; Naeim A
    J Geriatr Oncol; 2014 Oct; 5(4):368-75. PubMed ID: 25002322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China.
    Shen L; Li Q; Wang W; Zhu L; Zhao Q; Nie Y; Zhu B; Ma D; Lin X; Cai X; Fang W; Peng C; Chen Y; Fang H; Yin Z; Li H; Wang N; Xu R
    J Med Econ; 2020 May; 23(5):456-463. PubMed ID: 31950863
    [No Abstract]   [Full Text] [Related]  

  • 19. A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer.
    Kumar R; Jain K; Beeke C; Price TJ; Townsend AR; Padbury R; Roder D; Young GP; Richards A; Karapetis CS
    Cancer; 2013 Feb; 119(4):722-8. PubMed ID: 22990939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry.
    Tomita Y; Karapetis CS; Roder D; Beeke C; Hocking C; Roy AC; Townsend AR; Padbury R; Maddern G; Price TJ
    Aust J Rural Health; 2016 Apr; 24(2):85-91. PubMed ID: 26255652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.